|
NIP7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.518090E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.778400E-02 |
| Normal-vs-Stage2 |
1.909420E-01 |
| Normal-vs-Stage3 |
9.680800E-03 |
| Normal-vs-Stage4 |
8.728500E-02 |
| Stage1-vs-Stage2 |
9.312600E-01 |
| Stage1-vs-Stage3 |
2.123000E-01 |
| Stage1-vs-Stage4 |
4.573800E-01 |
| Stage2-vs-Stage3 |
3.965400E-01 |
| Stage2-vs-Stage4 |
4.930600E-01 |
| Stage3-vs-Stage4 |
9.103600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.038100E-02 |
| Normal-vs-AfricanAmerican |
4.237400E-03 |
| Normal-vs-Asian |
2.688600E-01 |
| Caucasian-vs-AfricanAmerican |
9.552100E-02 |
| Caucasian-vs-Asian |
4.962200E-01 |
| AfricanAmerican-vs-Asian |
6.463900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.659300E-03 |
| Normal-vs-Female |
4.472000E-02 |
| Male-vs-Female |
1.265990E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.095200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.520890E-03 |
| Normal-vs-Age(61-80Yrs) |
1.537760E-01 |
| Normal-vs-Age(81-100Yrs) |
9.083000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.686500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.930400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.075600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.475600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.713630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.268200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.153800E-01 |
| Classical-VS-Follicular |
4.723900E-02 |
| Classical-VS-Other |
1.552220E-01 |
| Classical-VS-Normal |
1.879200E-01 |
| Tall-VS-Follicular |
3.560800E-01 |
| Tall-VS-Other |
2.445800E-01 |
| Tall-VS-Normal |
2.415200E-01 |
| Follicular-VS-Other |
4.773800E-01 |
| Follicular-VS-Normal |
6.656500E-03 |
| Other-VS-Normal |
3.094400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.078360E-02 |
| Normal-vs-N1 |
1.268000E-01 |
| N0-vs-N1 |
8.731200E-01 |
|
|
